A high quality, sensitive biomarker can provide vital information to project teams throughout the discovery and development pipeline, information which can be used to instruct project progression strategies into the clinic.

We have developed expertise in the identification and validation of pharmacodynamic (PD) biomarker such as genes, proteins (including phosphoproteins and cytokines).

Our scientists offer biomarker identification and assay development expertise across a range of therapeutic areas.